AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17278015 — intervention group
Group type: COMPARATOR
Intervention: Salazosulfapyridine
Number of subjects: 376
Study 16044027 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol (100 mg twice daily for 6 months)
Number of subjects: 397
Study 16044027 — intervention group
Group type: COMPARATOR
Intervention: Ticlopidine (250 mg twice daily for 1 month)
Number of subjects: 397
Study 12366505 — intervention group
Group type: EXPERIMENTAL
Intervention: Single thermistor catheter with cold injectate (0 degrees C)
Number of subjects: 50
Study 12366505 — intervention group
Group type: EXPERIMENTAL
Intervention: Single thermistor catheter with room temperature injectate (20 degrees C)
Number of subjects: 50
Study 12366505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual thermistor catheter with cold injectate (0 degrees C)
Number of subjects: 50
Study 12366505 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual thermistor catheter with room temperature injectate (20 degrees C)
Number of subjects: 50
Study 9952145 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 MAC xenon with 0.6 MAC sevoflurane
Number of subjects: 40
Study 9952145 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 MAC xenon with 0.3 MAC sevoflurane
Number of subjects: 40
Study 9952145 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.7 MAC nitrous oxide with 0.6 MAC sevoflurane
Number of subjects: 40
Study 9952145 — intervention group
Group type: COMPARATOR
Intervention: 1.3 MAC sevoflurane
Number of subjects: 40
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with local anaesthetics (0/6)
Number of subjects: 25
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with non-steroidal anti-inflammatory drugs (2/3)
Number of subjects: 25
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with vinca-alkaloids (1/2)
Number of subjects: 25
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with corticosteroids (3/1)
Number of subjects: 25
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with morphine (0/1)
Number of subjects: 25
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with iodide (4/1)
Number of subjects: 25
Study 7771102 — intervention group
Group type: EXPERIMENTAL
Intervention: Iontophoresis with fluoride (0/1)
Number of subjects: 25
Study 7771102 — intervention group
Group type: COMPARATOR
Intervention: Placebo iontophoresis (lidocaine, procaine, flufenamic acid, diclofenac, Mobilat, vinca-alkaloids, dexamethasone-lidocaine, morphine, fluoride)
Number of subjects: 25
Study 7771102 — intervention group
Group type: COMPARATOR
Intervention: Topical administration (procaine, benzocaine-salicylamide, flufenamic acid)
Number of subjects: 25
Study 7771102 — intervention group
Group type: COMPARATOR
Intervention: Placebo administration without current (procaine, flufenamic acid)
Number of subjects: 25
Study 7771102 — intervention group
Group type: COMPARATOR
Intervention: Other methods (lidocaine, iodide)
Number of subjects: 25
Study 2178489 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam and fentanyl (continuous infusion)
Number of subjects: 24
Study 2178489 — intervention group
Group type: COMPARATOR
Intervention: Midazolam and fentanyl (intermittent bolus injections)
Number of subjects: 24
Study 2178489 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam and fentanyl (continuous infusion)
Number of subjects: 24
Study 2178489 — intervention group
Group type: COMPARATOR
Intervention: Diazepam and fentanyl (intermittent bolus injections)
Number of subjects: 24
Study 2178489 — intervention group
Group type: COMPARATOR
Intervention: Bolus technique
Number of subjects: 24
Study 2178489 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion
Number of subjects: 24
Study 6777812 — intervention group
Group type: EXPERIMENTAL
Intervention: High Dose (250 mg per week)
Number of subjects: 11
Study 6777812 — intervention group
Group type: COMPARATOR
Intervention: Low Dose (12.5 mg per week)
Number of subjects: 11
Study 31526476 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher intelligence
Number of subjects: 0
Study 31526476 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher educational attainment
Number of subjects: 0
Study 28545657 — intervention group
Group type: EXPERIMENTAL
Intervention: TEGDMA/HEMA-free resin composite system with 3-step etch-and-rinse adhesive (cmf-els)
Number of subjects: 67
Study 28545657 — intervention group
Group type: COMPARATOR
Intervention: 1-step HEMA-free self-etch adhesive (AdheSe One F)
Number of subjects: 67
Study 26951309 — intervention group
Group type: EXPERIMENTAL
Intervention: Apitolisib 40 mg once per day
Number of subjects: 85
Study 26951309 — intervention group
Group type: COMPARATOR
Intervention: Everolimus 10 mg once per day
Number of subjects: 85
Study 25027140 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (400 mg/d)
Number of subjects: 120
Study 25027140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study 25027140 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Number of subjects: 120
Study 22236497 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxycycline (200 mg/day for 6 weeks)
Number of subjects: 0
Study 22236497 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19151659 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF) 2 x 1 g daily for 6 months
Number of subjects: 98
Study 19151659 — intervention group
Group type: COMPARATOR
Intervention: Control group (fluocortolone and topical prednisolone acetate)
Number of subjects: 98
Study 19151659 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 98
Study 19151659 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 98
Study 17219171 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-BW (non-instrumental resistance training using body weight as a load, 3 times per week for 12 weeks)
Number of subjects: 52
Study 17219171 — intervention group
Group type: EXPERIMENTAL
Intervention: RT-BW
Number of subjects: 52
Study 17219171 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 52
Study 16368945 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-view posterior-anterior chest radiograph
Number of subjects: 154942
Study 12064338 — intervention group
Group type: EXPERIMENTAL
Intervention: Isomalt sweets
Number of subjects: 67
Study 12064338 — intervention group
Group type: COMPARATOR
Intervention: Sucrose sweets
Number of subjects: 67
Study 9438438 — intervention group
Group type: EXPERIMENTAL
Intervention: Multislice (2D) single‐shot spiral scan technique
Number of subjects: 9
Study 9438438 — intervention group
Group type: COMPARATOR
Intervention: Multislice (2D) EPI scan technique
Number of subjects: 9
Study 9438438 — intervention group
Group type: COMPARATOR
Intervention: 3D spiral scan technique
Number of subjects: 9
Study 1514666 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 micrograms formoterol
Number of subjects: 12
Study 1514666 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 micrograms formoterol
Number of subjects: 12
Study 1514666 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 micrograms terbutaline
Number of subjects: 12
Study 1514666 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 6209832 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution therapy (venesection of 250‐650 ml during the first 2 days and low‐molecular weight dextran administration)
Number of subjects: 52
Study 6209832 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 52
Study 6209832 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemodilution therapy
Number of subjects: 52
Study 30938314 — intervention group
Group type: EXPERIMENTAL
Intervention: One anastomosis gastric bypass
Number of subjects: 0
Study 30938314 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass
Number of subjects: 0
Study 29439736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula A (1.2 g/100 mL)
Number of subjects: 118
Study 29439736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula B (1.7 g/100 mL)
Number of subjects: 118
Study 29439736 — intervention group
Group type: COMPARATOR
Intervention: Breastfed infants (reference group)
Number of subjects: 118
Study 29439736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula A
Number of subjects: 118
Study 29439736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula B
Number of subjects: 118
Study 29439736 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula A and B
Number of subjects: 118
Study 26705066 — intervention group
Group type: EXPERIMENTAL
Intervention: Compression Sleeve (CS)
Number of subjects: 12
Study 26705066 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiology Tape (KT)
Number of subjects: 12
Study 26705066 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 12
Study 24748593 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET) - 24 sessions for 3 days/week for 40 min at moderate intensity
Number of subjects: 86
Study 24748593 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise Training (ET)
Number of subjects: 86
Study 24748593 — intervention group
Group type: COMPARATOR
Intervention: Control (Polymorphic group)
Number of subjects: 86
Study 22561561 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal intermittent positive pressure ventilation (NIPPV)
Number of subjects: 40
Study 22561561 — intervention group
Group type: COMPARATOR
Intervention: Control group (stable phase chronic obstructive pulmonary disease)
Number of subjects: 40
Study 22561561 — intervention group
Group type: EXPERIMENTAL
Intervention: NIPPV
Number of subjects: 40
Study 20841644 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Weight Assistant (HWA) web-based intervention for 12 weeks
Number of subjects: 297
Study 20841644 — intervention group
Group type: COMPARATOR
Intervention: Waiting list group (control)
Number of subjects: 297
Study 18782802 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free artificial tears (Group 1)
Number of subjects: 242
Study 18782802 — intervention group
Group type: EXPERIMENTAL
Intervention: Preservative-free artificial tears (Group 2)
Number of subjects: 242
Study 18782802 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears containing a preservative (Group 3)
Number of subjects: 242
Study 16670529 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (Lactobacillus acidophilus LA‐5 and Bifidobacterium animalis subsp. lactis BB‐12)
Number of subjects: 29
Study 16670529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 16670529 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics (AB‐Cap‐10)
Number of subjects: 29
Study 12970245 — intervention group
Group type: EXPERIMENTAL
Intervention: Micromed DeBakey VAD®
Number of subjects: 150
Study 10647066 — intervention group
Group type: EXPERIMENTAL
Intervention: Test diet with high soy protein and soluble fiber (12 +/- 2 g/d soy protein)
Number of subjects: 20
Study 10647066 — intervention group
Group type: COMPARATOR
Intervention: Control diet with low-fat dairy and low-soluble-fiber foods
Number of subjects: 20
Study 9296311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilazapril (2.5 mg)
Number of subjects: 55
Study 9296311 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 8346486 — intervention group
Group type: EXPERIMENTAL
Intervention: WEB 2086 (100 mg three times a day)
Number of subjects: 8
Study 8346486 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 3732901 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 N hydrochloric acid infusion
Number of subjects: 40
Study 3732901 — intervention group
Group type: COMPARATOR
Intervention: Normal saline infusion
Number of subjects: 40
Study 3732901 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1 N hydrochloric acid rechallenge
Number of subjects: 40
Study 3732901 — intervention group
Group type: COMPARATOR
Intervention: 0.1 N hydrochloric acid infusion in patients without duodenal ulcer
Number of subjects: 40
Study 29546361 — intervention group
Group type: EXPERIMENTAL
Intervention: D3 + TL (Day 3 single embryo transfer with time-lapse hierarchical classification model)
Number of subjects: 600
Study 29546361 — intervention group
Group type: COMPARATOR
Intervention: D5 + CM (Day 5 single embryo transfer with conventional morphological selection)
Number of subjects: 600
Study 29546361 — intervention group
Group type: EXPERIMENTAL
Intervention: D3 + TL
Number of subjects: 600
Study 29546361 — intervention group
Group type: COMPARATOR
Intervention: D5 + CM
Number of subjects: 600
Study 27876082 — intervention group
Group type: EXPERIMENTAL
Intervention: DAA‐facilitated single abstraction plus verification by a second person
Number of subjects: 48
Study 27876082 — intervention group
Group type: COMPARATOR
Intervention: Traditional (non‐DAA‐facilitated) single abstraction plus verification by a second person
Number of subjects: 48
Study 27876082 — intervention group
Group type: COMPARATOR
Intervention: Traditional independent dual abstraction plus adjudication
Number of subjects: 48
Study 24160414 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (24 IU)
Number of subjects: 24
Study 24160414 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 21944168 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity weight-lifting exercise and targeted multidisciplinary treatment
Number of subjects: 124
Study 20485957 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% ropivacaine (Ropi Group)
Number of subjects: 30
Study 20485957 — intervention group
Group type: COMPARATOR
Intervention: 0.5% bupivacaine with epinephrine (Bupi Group)
Number of subjects: 30
Study 19026891 — intervention group
Group type: EXPERIMENTAL
Intervention: 14.3% EDTA
Number of subjects: 30
Study 19026891 — intervention group
Group type: EXPERIMENTAL
Intervention: SmearClear
Number of subjects: 30
Study 19026891 — intervention group
Group type: COMPARATOR
Intervention: Control (no smear layer removal procedure)
Number of subjects: 30
Study 16078916 — intervention group
Group type: EXPERIMENTAL
Intervention: Tranexamic acid (TA)
Number of subjects: 9
Study 16078916 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study 12055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral supplementation for 5 days with 1 L/day of a formula enriched with arginine, omega-3 fatty acids, and RNA (n = 102)
Number of subjects: 305
Study 12055582 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative oral supplementation plus postoperative jejunal infusion with the same enriched formula (n = 101)
Number of subjects: 305
Study 12055582 — intervention group
Group type: COMPARATOR
Intervention: No artificial nutrition before and after surgery (conventional group; n = 102)
Number of subjects: 305
Study 10606379 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 2% diclofenac in lecithin organogel
Number of subjects: 70
Study 10606379 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 70
Study 8695584 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (0.3 mg/kg) administered at home 60 minutes before treatment
Number of subjects: 25
Study 8695584 — intervention group
Group type: COMPARATOR
Intervention: Placebo administered at home 60 minutes before treatment
Number of subjects: 25
Study 8695584 — intervention group
Group type: COMPARATOR
Intervention: Control (no diazepam or placebo)
Number of subjects: 25
Study 2064345 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (2x20 mg/day)
Number of subjects: 116
Study 2064345 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen + Prednisolone (3x2.5 mg/day)
Number of subjects: 116
Study 6677080 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-year primary prevention program consisting of drug education, 'alternatives,' and affective in-service training for teachers.
Number of subjects: 0
Study 6677080 — intervention group
Group type: COMPARATOR
Intervention: No treatment (control group)
Number of subjects: 0
Study 30769293 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct hemoperfusion with polymyxin B immobilized cartridge (DHP‐PMX)
Number of subjects: 0
Study 30769293 — intervention group
Group type: COMPARATOR
Intervention: No DHP‐PMX therapy
Number of subjects: 0
Study 29927273 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers (WW)
Number of subjects: 130
Study 29927273 — intervention group
Group type: COMPARATOR
Intervention: Self-guided control (SG)
Number of subjects: 130
Study 26771340 — intervention group
Group type: EXPERIMENTAL
Intervention: High eating frequency
Number of subjects: 115
Study 25618970 — intervention group
Group type: EXPERIMENTAL
Intervention: Gushenyutai plaster plus comprehensive therapy
Number of subjects: 62
Study 25618970 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive therapy alone
Number of subjects: 62
Study 21769610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to reproduce learning in the future with self-controlled feedback
Number of subjects: 0
Study 21769610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to learn with low feedback schedule
Number of subjects: 0
Study 21769610 — intervention group
Group type: EXPERIMENTAL
Intervention: Intention to learn with high feedback schedule
Number of subjects: 0
Study 19207748 — intervention group
Group type: EXPERIMENTAL
Intervention: Waiting period of 30 min (Group I, n = 70)
Number of subjects: 138
Study 19207748 — intervention group
Group type: COMPARATOR
Intervention: No waiting period (Group II, n = 68)
Number of subjects: 138
Study 17328070 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide (CYC)
Number of subjects: 39
Study 17328070 — intervention group
Group type: COMPARATOR
Intervention: Azathioprine (AZA) plus Methylprednisolone (MP)
Number of subjects: 39
Study 17328070 — intervention group
Group type: EXPERIMENTAL
Intervention: Both CYC and AZA
Number of subjects: 39
Study 15239288 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant chemotherapy (5‐FU + leucovorin)
Number of subjects: 28
Study 15239288 — intervention group
Group type: COMPARATOR
Intervention: Control (surgery only)
Number of subjects: 28
Study 11559727 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment by surgeons treating more than 10 cases
Number of subjects: 673
Study 11559727 — intervention group
Group type: EXPERIMENTAL
Intervention: Free radial margins
Number of subjects: 673
Study 11559727 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor adherence to adjacent structures
Number of subjects: 673
Study 11559727 — intervention group
Group type: EXPERIMENTAL
Intervention: T and N classification
Number of subjects: 673
Study 11559727 — intervention group
Group type: EXPERIMENTAL
Intervention: Number and percentage of positive nodes
Number of subjects: 673
Study 11559727 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes
Number of subjects: 673
Study 9717852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost-effectiveness analysis
Number of subjects: 0
Study 9717852 — intervention group
Group type: EXPERIMENTAL
Intervention: Cost per quality-adjusted life-year
Number of subjects: 0
Study 9717852 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision trees
Number of subjects: 0
Study 7750185 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment skill of pause and regress in six parts
Number of subjects: 310
Study 7750185 — intervention group
Group type: COMPARATOR
Intervention: Uniform reinforcing‐reducing method
Number of subjects: 310
Study 2702881 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone 40 micrograms/kg/hr
Number of subjects: 12
Study 2702881 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 2702881 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 12
Study 4210065 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast neutron therapy
Number of subjects: 238
Study 30113521 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimalist shoe walking (MSW)
Number of subjects: 57
Study 30113521 — intervention group
Group type: EXPERIMENTAL
Intervention: Foot strengthening (FS) exercise
Number of subjects: 57
Study 30113521 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 57
Study 28279546 — intervention group
Group type: EXPERIMENTAL
Intervention: Green Dot intervention
Number of subjects: 89707
Study 28279546 — intervention group
Group type: COMPARATOR
Intervention: Control (wait list)
Number of subjects: 89707
Study 25214312 — intervention group
Group type: EXPERIMENTAL
Intervention: DaVinci robotic‐assisted laparoscopic prostatectomy (RARP)
Number of subjects: 255
Study 25214312 — intervention group
Group type: COMPARATOR
Intervention: Open radical retropubic prostatectomy (RRP)
Number of subjects: 255
Study 23135774 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (1.5 mg/kg within 0.9% saline solution)
Number of subjects: 90
Study 23135774 — intervention group
Group type: EXPERIMENTAL
Intervention: Levobupivacaine (0.25% in 0.9% saline solution)
Number of subjects: 90
Study 23135774 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline solution)
Number of subjects: 90
Study 21989388 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined stimulation of distant electrode contacts located in the subthalamic nucleus and caudal border zone of STN and substantia nigra pars reticulata [STN+SNr]
Number of subjects: 12
Study 21989388 — intervention group
Group type: COMPARATOR
Intervention: Conventional stimulation of the subthalamic nucleus [STNmono]
Number of subjects: 12
Study 18497598 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 43
Study 18497598 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane (Control)
Number of subjects: 43
Study 17174704 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-nucleoside reverse transcriptase inhibitor (NNRTI) strategy (NNRTI plus NRTI; n=463)
Number of subjects: 1397
Study 17174704 — intervention group
Group type: COMPARATOR
Intervention: Protease inhibitor (PI) strategy (PI plus NRTI; n=470)
Number of subjects: 1397
Study 17174704 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-class strategy (PI plus NNRTI plus NRTI; n=464)
Number of subjects: 1397
Study 17174704 — intervention group
Group type: COMPARATOR
Intervention: Combined two-class strategies (NNRTI plus NRTI or PI plus NRTI)
Number of subjects: 1397
Study 14601763 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential conditional probability ratio tests (SCPRTs)
Number of subjects: 0